Greater integration is to take place between the US and UK following an expansion says Cresset, a provider of integrated in-silico solutions for drug discovery.
BioCina Pty Ltd., a global end-to-end biologics Contract Development and Manufacturing Organisation (CDMO), and NovaCina Pty Ltd., a global fill-and-finish CDMO, announced a strategic partnership to provide integrated drug substance and drug product solutions for biologics developers. This alliance enables BioCina to offer the highest quality fill-and-finish solutions to their clients, to convert the drug substance produced at its state-of-the-art Adelaide, South Australia facility into ready-to
Western Asset Mortgage Opportunity Fund Inc. (NYSE:DMO – Get Free Report) announced a monthly dividend on Tuesday, February 20th, NASDAQ reports. Shareholders of record on Thursday, March 21st will be given a dividend of 0.125 per share by the investment management company on Monday, April 1st. This represents a $1.50 dividend on an annualized basis […]